Enas M Kamal

4PUBLICATIONS
4CO-AUTHORS
Infant and child healthAdolescent healthCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 24, 2019
Effects of sofosbuvir/ledipasvir therapy on chronic hepatitis C virus genotype 4, infected children of 3-6 years of age.

Enas M Kamal, Mortada El-Shabrawi, Hisham El-Khayat

|Apr 27, 2018
A pilot single arm observational study of sofosbuvir/ledipasvir (200 + 45 mg) in 6- to 12- year old children.

M H F El-Shabrawi, N M Kamal, H R El-Khayat

|Jan 20, 2018
The effectiveness and safety of ledipasvir plus sofosbuvir in adolescents with chronic hepatitis C virus genotype 4 infection: a real-world experience.

H R El-Khayat, E M Kamal, M H El-Sayed

|Jan 10, 2018
Sofosbuvir plus daclatasvir with or without ribavirin in 551 patients with hepatitis C-related cirrhosis, genotype 4.

H El-Khayat, Y Fouad, H I Mohamed

Pageof 1

Frequent Collaborators

2 joint publications

Dina Attia

2 joint publications

Mostafa Yakoot

1 joint publications

H I Mohamed

1 joint publications

N M Kamal